Startups and pharmas integrated generative and predictive models into molecular design, with early clinical candidates.
After AlphaFold, firms used generative molecule models, learned docking, and multi-objective optimization to propose candidates.
Early clinical-trial successes were celebrated cautiously: translational biology remains the hard filter, not only the model.
The sector illustrates AI for science with clearer business and regulatory (FDA) metrics than general chat.
Semiconductor Report in September 2026 describes how AI demand is tightening DRAM/NAND/HBM, PMICs, controllers, and PCB FR-4 materials: PMIC lead times from 6–8 to 12–16 weeks; some suppliers stop taking new orders; copper foil prioritized for high-frequency laminates; FR-4 lead times from 2 to 4–6 weeks. Tightness may persist into 2027.
On September 14, 2026, Forbes and RuntimeWire covered Cognichip’s enterprise launch of Artificial Chip Intelligence (ACI), founded by Faraj Aalaei. The system uses native physics-informed models—not LLM wrappers—for microarchitecture, RTL, verification and PPA; one cited case compressed a 55-page spec into days versus 4–5 months. Public evidence remains company and customer benchmarks.
In late September 2026 Oracle sent a force majeure notice to a Blue Owl/STACK Infrastructure subsidiary on Project Jupiter in Doña Ana County, New Mexico, citing power delays, air-quality permits for the microgrid and a gas pipeline. Reuters, Bloomberg and local press report Oracle is protecting contractual rights against a ~2028 operational target, without abandoning the project.